Our findings indicate that SMAD2 signaling and SMAD1 signaling as well as ERK signaling are responsible for defective early bone development in CFC syndrome, providing a novel insight on the pathological mechanism and therapeutic targets. This evidence concerns the gene SMAD2 and cardiofaciocutaneous syndrome.